Scroll To Top
Search by Speciality

The 4th Annual Traumatic Brain Injury Conference (TBI 2014)

DoubleTree by Hilton Hotel Washington DC * | Washington, USA
From 295 to 1195 USD
Event Preview
This event
is Finished
Title: The 4th Annual Traumatic Brain Injury Conference (TBI 2014)
Specialty: , Neurology, Neurosurgery
Dates: From Apr, 16, 2014 to Apr, 17, 2014
Location: Washington, USA
Type: Conference
Registration Cost: From 295 to 1195 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Washington, Usa.
General Info
Event Venue:

DoubleTree by Hilton Hotel Washington DC *

Washington, USA Visit the Venue to read more
Event Overview
Welcome message:

The 4th Annual Traumatic Brain Injury Conference (TBI 2014) will be held in Washington, DC, United States on April 16-17, 2014.

The The 4th Annual Traumatic Brain Injury Conference (TBI 2014) covers topics such as:

  • Drug Discovery & Development
  • Neuroimaging
  • Pre-clinical Models
  • Clinical Trial Design
  • Biomarkers
  • Cognitive Measures of TBI
  • Neurodegenerative Diseases and Implications for TBI Therapy Development
  • Chronic Outcome of TBI and TBI-related Dementia

The The 4th Annual Traumatic Brain Injury Conference (TBI 2014) brings together Brain Injury Research Associates, Associate Scientists, Chief Medical Officers, CEOs, Directors, Clinical Research Coordinator, Managers, Group Leaders, Principal Investigator and Medical Directors.

Now in its 4th year, Arrowhead's Annual TRAUMATIC BRAIN INJURY CONFERENCE has in past years brought together researchers and clinicians from industry, academia, the military and government to present ground-breaking research in a variety of areas related to traumatic brain injury, including

  • Neuroimaging

  • Drug Discovery & Development

  • Clinical Trial Design

  • Pre-clinical Models

  • Cognitive Measures of TBI

  • Biomarkers

  • Chronic Outcome of TBI and TBI-related Dementia

  • Neurodegenerative Diseases and Implications for TBI Therapy Development

Charles Bernick, MD, Associate Medical Director, Lou Ruvo Center for Brain Health, Cleveland Clinic

Mikael Brönnegård, MD., Ph.D., Associate Professor, Karolinska Institute, Chief Executive Officer, NeuroVive Pharmaceutical AB

Stuart Blincko, Ph.D., Sr. Principal Research Scientist, Abbott Diagnostics

Peter Como, Ph.D. (tentative), Lead Reviewer, Neuropsychologist, Division of Ophthalmic, Neurological & Ear, Nose & Throat Devices (DONED), Neurodiagnostic and Neurotherapeutic Devices Branch (NNDB), US Food & Drug Administration

Nicholas Conti, Ph.D., Vice President, Business Development, Quest Diagnostics

Ralph G DePalma, MD, FACS, Special Operations Officer, VA Office of Research & Development, Professor of Surgery, Uniformed Services University of the Health Sciences

Ramon Diaz-Arrastia, MD, Ph.D., Professor of Neurology, Uniformed Services University of the Health Sciences, Director of Clinical Research, Center for Neuroscience & Regenerative Medicine

Alan Faden, MD, David S. Brown Professor in Trauma, Professor, Departments of Anesthesiology, Anatomy & Neurobiology, Neurosurgery, and Neurology, Director, Center for Shock, Trauma & Anesthesiology Research (STAR), University of Maryland School of Medicine

Sam Gandy, MD, Ph.D., Professor of Neurology and Psychiatry (Dual Primary Appointments), Mount Sinai Chair in Alzheimer’s Disease Research, Director, Mount Sinai Center for Cognitive Health and NFL Neurological Care, Associate Director, Mount Sinai Alzheimer’s Disease Research Center, Mount Sinai School of Medicine and James J Peters VA Medical Center

Joshua Gatson, Ph.D., Assistant Professor, Division of Burn/Trauma/Critical Care, Department of Surgery, UT Southwestern Medical Center

Larry Glass, CEO, Neuren Pharmaceuticals

Ronald L. Hayes, Ph.D., Founder & President, Banyan Biomarkers

Kim A. Heidenreich, Ph.D., Professor, Department of Pharmacology, Neuroscience Program, University of Colorado School of Medicine,Anschutz Medical Center

Graham Hubler, Ph.D., Director, Sydney Kimmel Institute for Nuclear Renaissance (SKINR), Department of Physics and Astronomy,University of Missouri

Andreas Jeromin, Ph.D., Chief Scientific Officer, NextGen Sciences

Andrew Maas, MD, Ph.D., Professor & Chairman, Department of Neurosurgery, University Hospital Antwerp

Thomas W. MacAllister, JD, Ph.D., President & Chief Executive Officer, BHR Pharma, LLC

Geoffrey T. Manley, MD, Ph.D., Professor and Vice Chairman of Neurological Surgery, University of California, San Francisco, Chief of Neurosurgery, San Francisco General Hospital, Co-Director, Brain and Spinal Injury Center (BASIC)

Andrew Mayer, Ph.D., Associate Professor of Translational Neuroscience, The Mind Research Network, Adjunct Assistant Professor of Neurology and Psychology, University of New Mexico

Guy Miller, MD, Ph.D., Chairman and Chief Executive Officer, Edison Pharmaceuticals, Inc.

Mark Mintun, MD, Chief Medical Officer, Avid Radiopharmaceuticals (Eli Lilly & Co.)

Gregory P. Mueller, Ph.D., Professor, Vice Chair for Research, Uniformed Services University of the Health Sciences

Giulio Maria Pasinetti, MD, Ph.D., Professor of Psychiatry, Neuroscience, Geriatrics and Adult Development, Department of Psychiatry,Mount Sinai School of Medicine

Daniel Perl, MD, Professor of Pathology (Neuropathology), Uniformed Services University of the Health Sciences

Paul Rapp, Ph.D., Professor of Military and Emergency Medicine, Uniformed Services University, Director, Traumatic Injury Research Program

Roger Sabbadini, Ph.D., Vice President & Founder, Lpath, Inc.

Deborah A. Shear, Ph.D., Neuroprotection Section Chief, Brain Trauma Neuroprotection and Neurorestoration Branch, Center for Military Psychiatry and Neuroscience (CMPN), Walter Reed Army Institute of Research

Martha Shenton, Ph.D., Professor and Director, Psychiatry Neuroimaging Laboratory, Department of Psychiatry,  Brigham and Women's Hospital, Harvard Medical School

Adam J. Simon, Ph.D., President & CEO, Cerora, Inc.

Robert A. Stern, Ph.D., Professor of Neurology and Neurosurgery, Center for the Study of Traumatic Encephalopathy, Director, Clinical Core, BU Alzheimer's Disease Center, Boston University School of Medicine

Frank Tegtmeier, Ph.D., Chief Scientific Officer, vasopharm

Jeff Victoroff, MD, Associate Professor Clinical Neurology & Psychiatry, University of Southern California School of Medicine

Registration Not yet available Register Now
Scientific Content Up to Date
Sponsors Exhibitors
Organising Agency
Arrowhead Publishers & Conferences
5780 Lincoln Drive
Suite 142

Telephone: 866-945-0263
Fax: 866-945-0263
Event map
Revelant Events